JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3779 RS 504393
1 Citation

Summary: CCR2 chemokine receptor antagonist

≥8.28 mg/mL
A3817 Sildenafil

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor, selective

≥22.65 mg/mL
A3858 Taranabant

Summary: Cannabinoid receptor type 1 inverse agonist

Soluble in DMSO
A3860 Tasquinimod

Summary: Antiangiogenic and antineoplastic agent

insoluble in H2O; ≥20.32 mg/mL
A3877 Tirofiban hydrochloride monohydrate

Summary: Glycoprotein IIb/IIIa inhibitor

≥4.95 mg/mL
A3885 Tozadenant

Target: Adenosine A2A Receptors

Summary: Adenosine 2a receptor antagonist,novel and selective

insoluble in EtOH; insoluble in H2O; ≥20.35 mg/mL
A3920 Vinblastine sulfate
2 Citation

Summary: Anti-mitotic agent

≥28.85 mg/mL
A3935 WEHI-539
15 Citation

Target: Bcl-xl

Summary: Bcl-xL inhibitor,potent and selective

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
A3940 XL388

Summary: MTOR inhibitor,highly potent and selective

insoluble in EtOH; insoluble in H2O; ≥6.87 mg/mL
A4410 Acetyl-Calpastatin (184-210) (human)

Summary: Calpain I/II inhibitor

Soluble to 5 mg/mL